Understanding the Association Between Antidepressants and the Risk of Being Diagnosed with Dementia in Older People: A Self-Controlled Case Series Study
Restricted accessResearch articleFirst published online November 10, 2020
Understanding the Association Between Antidepressants and the Risk of Being Diagnosed with Dementia in Older People: A Self-Controlled Case Series Study
Given concerns about adverse outcomes for older people taking antidepressants in the literature, we investigated whether taking antidepressants elevates the risk of dementia.
Objective:
This study aims to investigate the putative association of antidepressants with the risk of dementia.
Methods:
We conducted a population-based self-controlled case series analysis of older people with dementia and taking antidepressants, using territory-wide medical records of 194,507 older patients collected by the Hospital Authority of Hong Kong, to investigate the association between antidepressant treatment and the risk of developing dementia in older people.
Results:
There was a significantly higher risk of being diagnosed with dementia during the pre-drug-exposed period (incidence rate ratio (IRR) 20.42 (95% CI: 18.66–22.34)) compared to the non-drug-exposed baseline period. The IRR remained high during the drug-exposed period (IRR 8.86 (7.80–10.06)) before returning to a baseline level after washout (IRR 1.12 (0.77–1.36)).
Conclusion:
The higher risk of dementia before antidepressant treatment may be related to emerging psychiatric symptoms co-occurring with dementia, which trigger medical consultations that result in a decision to begin antidepressants. Our findings do not support a causal relationship between antidepressant treatment and the risk of dementia.
CouplandCAC, HillT, DeningT, MorrissR, MooreM, Hippisley-CoxJ (2019) Anticholinergic drug exposure and the risk of dementia: A nested case-control study. JAMA Intern Med179, 1084–1093.
6.
GraySL, AndersonML, DublinS, HanlonJT, HubbardR, WalkerR, YuO, CranePK, LarsonEB (2015) Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med175, 401–407.
7.
LeeCWS, LinCL, SungFC, LiangJA, KaoCH (2016) Antidepressant treatment and risk of dementia: A population-based, retrospective case-control study. J Clin Psychiatry77, 117–122.
8.
HeathLM, GraySL, BoudreauD, EdwardsKL, FullertonSM, ThummelK, LarsonEB (2016) Common antidepressant medications and risk of dementia: A prospective cohort study. Alzheimers Dement12, P1135–P1135.
9.
HanL (2009) Antidepressant drug use and cognitive deficits in older men: Addressing confounding by indication using different methods. Alzheimers Dement5, e7–e7.
10.
KorczynAD, HalperinI (2009) Depression and dementia. J Neurol Sci283, 139–142.
11.
MorarosJ, NwankwoC, PattenSB, MousseauDD (2017) The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. Depress Anxiety34, 217–226.
12.
HanL, McCuskerJ, ColeM, CapekR, AbrahamowiczM (2010) Antidepressant use and cognitive function in older primary care patients with major or minor depression: A prospective cohort study with database linkage. Alzheimers Dement6, S468–S468.
13.
AlmondesKM, CostaMV, Malloy-DinizLF, DinizBS (2016) Insomnia and risk of dementia in older adults: Systematic review and meta-analysis. J Psychiatr Res77, 109–115.
14.
CaiL, HuangJ (2018) Schizophrenia and risk of dementia: A meta-analysis study. Neuropsychiatr Dis Treat14, 2047–2055.
15.
ChanEW, LauWCY, LeungWK, MokMTC, HeY, TongTSM, WongICK, GibD (2015) Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: A population-based study. Gastroenterology149, 586–595.e3.
16.
ManKKC, CoghillD, ChanEW, LauWCY, HollisC, LiddleE, BanaschewskiT, McCarthyS, NeubertA, SayalK, IpP, SchuemieMJ, SturkenboomMCJM, Sonuga-BarkeE, BuitelaarJ, CarucciS, ZuddasA, KovshoffH, GarasP, NagyP, InglisSK, KonradK, HägeA, RosenthalE, WongICK (2017) Association of risk of suicide attempts with methylphenidate treatment. JAMA Psychiatry74, 1048–1055.
17.
ManKKC, CoghillD, ChanEW, LauWCY, HollisC, LiddleE, BanaschewskiT, MccarthyS, NeubertA (2016) Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system. Transl Psychiatry6, e956.
18.
ManK, LauWCY, CoghillD, BesagFMC, CrossJH, IpP, WongI (2020) Association between methylphenidate treatment and risk of seizure: A population-based self-controlled case series study. Lancet Child Adolesc Health4, 435–443.
19.
ChuiCS, ManKK, ChengCL, ChanEW, LauWC, ChengVC, WongDS, Yang KaoYH, WongIC (2014) An investigation of the potential association between retinal detachment and oral fluoroquinolones: A self-controlled case series study. J Antimicrob Chemother69, 2563–2567.
20.
WongAYS, RootA, DouglasIJ, ChuiCSL, ChanEW, Ghebremichael-weldeselassieY, SiuC, SmeethL, WongICK (2016) Cardiovascular outcomes associatedwith use of clarithromycin: Population based study. BMJ352, h6926.
21.
LauWCY, ChanEW, CheungCL, SingCW, ManKKC, LipGYH, SiuCW, LamJKY, LeeACH, WongICK (2017) Association between Dabigatran vs Warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation. JAMA317, 1151–1158.
22.
RoseE, GlymourMM, QuesenberryCP, WhitmerRA (2016) Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement12, 216–224.
23.
GilsanzP, MayedaER, GlymourMM, QuesenberryCP, WhitmerRA (2017) Association between birth in a high stroke mortality state, race, and risk of dementia. JAMA Neurol74, 1056–1062.
WhitakerHJ, FarringtonCP, SpiessensB, MusondaP (2006) Tutorial in biostatistics: The self-controlled case series method. Stat Med25, 1768–1797.
26.
ManKKC, ChanEW, CoghillD, DouglasI, IpP, LeungLP, TsuiMSH, WongWHS, WongICK (2015) Methylphenidate and the risk of trauma. Pediatrics135, 40–48.
27.
Ghebremichael-WeldeselassieY, WhitakerHJ, FarringtonCP (2016) Flexible modelling of vaccine effect in self-controlled case series models. Biometrical J58, 607–622.
28.
HofmanA, BretelerMMB, OttA, StolkRP, van HarskampF, PolsHAP (2009) Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. Neurology53, 1992–1997.
PodcasyJL, EppersonCN (2016) Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin Neurosci18, 437–446.
31.
MielkeMM (2018) Sex and gender differences in Alzheimer disease dementia. Psychiatr Times35, 14–15.
32.
LinFC, ChuangYS, HsiehHM, LeeTC, ChiuKF, LiuCK, WuMT (2015) Early statin use and the progression of Alzheimer disease: A total population-based case-control study. Medicine (Baltimore)94, e2143.
33.
MielkeMM, VemuriP, RoccaWA (2014) Clinical epidemiology of Alzheimer’s disease: Assessing sex and gender differences. Clin Epidemiol6, 37–48.
34.
De VriesPJ, HonerWG, KempPM, McKennaPJ (2001) Dementia as a complication of schizophrenia. J Neurol Neurosurg Psychiatry70, 588–596.
35.
ArmstrongSC, CozzaKL, WatanabeKS (1997) The misdiagnosis of delirium. Psychosomatics38, 433–439.
36.
PerlisRH (2005) Misdiagnosis of bipolar disorder. Am J Manag Care11, 57–63.
37.
LanganSM, MinassianC, SmeethL, ThomasSL (2014) Risk of stroke following herpes zoster: A self-controlled case-series study. Clin Infect Dis58, 1497–1503.
